|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:ALG6-SLC22A15 (FusionGDB2 ID:HG29929TG55356) |
Fusion Gene Summary for ALG6-SLC22A15 |
Fusion gene summary |
Fusion gene information | Fusion gene name: ALG6-SLC22A15 | Fusion gene ID: hg29929tg55356 | Hgene | Tgene | Gene symbol | ALG6 | SLC22A15 | Gene ID | 29929 | 55356 |
Gene name | ALG6 alpha-1,3-glucosyltransferase | solute carrier family 22 member 15 | |
Synonyms | CDG1C | FLIPT1|PRO34686 | |
Cytomap | ('ALG6')('SLC22A15') 1p31.3 | 1p13.1 | |
Type of gene | protein-coding | protein-coding | |
Description | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferaseMan(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferaseasparagine-linked glycosylation 6 homolog (S. cerevisiae, alpha-1,3-glucosyltransferase)asparagine-linked glycosylation 6 homolog (yeast | solute carrier family 22 member 15flipt 1fly-like putative organic ion transporter 1fly-like putative transporter 1solute carrier family 22 (organic cation transporter), member 15trans-like protein | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000263440, ENST00000371108, ENST00000494765, | ||
Fusion gene scores | * DoF score | 10 X 8 X 6=480 | 5 X 4 X 4=80 |
# samples | 10 | 5 | |
** MAII score | log2(10/480*10)=-2.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/80*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ALG6 [Title/Abstract] AND SLC22A15 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ALG6(63836730)-SLC22A15(116569514), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | ALG6-SLC22A15 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ALG6-SLC22A15 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ALG6 | GO:0006487 | protein N-linked glycosylation | 10924277 |
Fusion gene breakpoints across ALG6 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across SLC22A15 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | SKCM | TCGA-EB-A44R-06A | ALG6 | chr1 | 63836730 | - | SLC22A15 | chr1 | 116569514 | + |
Top |
Fusion Gene ORF analysis for ALG6-SLC22A15 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000263440 | ENST00000481127 | ALG6 | chr1 | 63836730 | - | SLC22A15 | chr1 | 116569514 | + |
5CDS-intron | ENST00000371108 | ENST00000481127 | ALG6 | chr1 | 63836730 | - | SLC22A15 | chr1 | 116569514 | + |
In-frame | ENST00000263440 | ENST00000369502 | ALG6 | chr1 | 63836730 | - | SLC22A15 | chr1 | 116569514 | + |
In-frame | ENST00000263440 | ENST00000369503 | ALG6 | chr1 | 63836730 | - | SLC22A15 | chr1 | 116569514 | + |
In-frame | ENST00000371108 | ENST00000369502 | ALG6 | chr1 | 63836730 | - | SLC22A15 | chr1 | 116569514 | + |
In-frame | ENST00000371108 | ENST00000369503 | ALG6 | chr1 | 63836730 | - | SLC22A15 | chr1 | 116569514 | + |
intron-3CDS | ENST00000494765 | ENST00000369502 | ALG6 | chr1 | 63836730 | - | SLC22A15 | chr1 | 116569514 | + |
intron-3CDS | ENST00000494765 | ENST00000369503 | ALG6 | chr1 | 63836730 | - | SLC22A15 | chr1 | 116569514 | + |
intron-intron | ENST00000494765 | ENST00000481127 | ALG6 | chr1 | 63836730 | - | SLC22A15 | chr1 | 116569514 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000371108 | ALG6 | chr1 | 63836730 | - | ENST00000369503 | SLC22A15 | chr1 | 116569514 | + | 4379 | 387 | 305 | 1432 | 375 |
ENST00000371108 | ALG6 | chr1 | 63836730 | - | ENST00000369502 | SLC22A15 | chr1 | 116569514 | + | 1005 | 387 | 305 | 526 | 73 |
ENST00000263440 | ALG6 | chr1 | 63836730 | - | ENST00000369503 | SLC22A15 | chr1 | 116569514 | + | 4282 | 290 | 208 | 1335 | 375 |
ENST00000263440 | ALG6 | chr1 | 63836730 | - | ENST00000369502 | SLC22A15 | chr1 | 116569514 | + | 908 | 290 | 208 | 429 | 73 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000371108 | ENST00000369503 | ALG6 | chr1 | 63836730 | - | SLC22A15 | chr1 | 116569514 | + | 0.003186337 | 0.9968137 |
ENST00000371108 | ENST00000369502 | ALG6 | chr1 | 63836730 | - | SLC22A15 | chr1 | 116569514 | + | 0.1547654 | 0.84523463 |
ENST00000263440 | ENST00000369503 | ALG6 | chr1 | 63836730 | - | SLC22A15 | chr1 | 116569514 | + | 0.003297908 | 0.99670213 |
ENST00000263440 | ENST00000369502 | ALG6 | chr1 | 63836730 | - | SLC22A15 | chr1 | 116569514 | + | 0.21381518 | 0.78618485 |
Top |
Fusion Genomic Features for ALG6-SLC22A15 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Top |
Fusion Protein Features for ALG6-SLC22A15 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:63836730/chr1:116569514) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ALG6 | chr1:63836730 | chr1:116569514 | ENST00000371108 | - | 2 | 15 | 4_24 | 27 | 508.0 | Transmembrane | Helical |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369502 | 3 | 6 | 529_535 | 199 | 246.0 | Compositional bias | Note=Poly-Glu | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369503 | 3 | 12 | 529_535 | 199 | 548.0 | Compositional bias | Note=Poly-Glu | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369502 | 3 | 6 | 201_221 | 199 | 246.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369502 | 3 | 6 | 226_246 | 199 | 246.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369502 | 3 | 6 | 303_323 | 199 | 246.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369502 | 3 | 6 | 338_358 | 199 | 246.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369502 | 3 | 6 | 368_388 | 199 | 246.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369502 | 3 | 6 | 401_420 | 199 | 246.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369502 | 3 | 6 | 433_453 | 199 | 246.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369502 | 3 | 6 | 462_482 | 199 | 246.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369503 | 3 | 12 | 201_221 | 199 | 548.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369503 | 3 | 12 | 226_246 | 199 | 548.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369503 | 3 | 12 | 303_323 | 199 | 548.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369503 | 3 | 12 | 338_358 | 199 | 548.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369503 | 3 | 12 | 368_388 | 199 | 548.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369503 | 3 | 12 | 401_420 | 199 | 548.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369503 | 3 | 12 | 433_453 | 199 | 548.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369503 | 3 | 12 | 462_482 | 199 | 548.0 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ALG6 | chr1:63836730 | chr1:116569514 | ENST00000371108 | - | 2 | 15 | 115_135 | 27 | 508.0 | Transmembrane | Helical |
Hgene | ALG6 | chr1:63836730 | chr1:116569514 | ENST00000371108 | - | 2 | 15 | 144_164 | 27 | 508.0 | Transmembrane | Helical |
Hgene | ALG6 | chr1:63836730 | chr1:116569514 | ENST00000371108 | - | 2 | 15 | 173_193 | 27 | 508.0 | Transmembrane | Helical |
Hgene | ALG6 | chr1:63836730 | chr1:116569514 | ENST00000371108 | - | 2 | 15 | 227_247 | 27 | 508.0 | Transmembrane | Helical |
Hgene | ALG6 | chr1:63836730 | chr1:116569514 | ENST00000371108 | - | 2 | 15 | 298_318 | 27 | 508.0 | Transmembrane | Helical |
Hgene | ALG6 | chr1:63836730 | chr1:116569514 | ENST00000371108 | - | 2 | 15 | 324_344 | 27 | 508.0 | Transmembrane | Helical |
Hgene | ALG6 | chr1:63836730 | chr1:116569514 | ENST00000371108 | - | 2 | 15 | 362_382 | 27 | 508.0 | Transmembrane | Helical |
Hgene | ALG6 | chr1:63836730 | chr1:116569514 | ENST00000371108 | - | 2 | 15 | 388_408 | 27 | 508.0 | Transmembrane | Helical |
Hgene | ALG6 | chr1:63836730 | chr1:116569514 | ENST00000371108 | - | 2 | 15 | 438_458 | 27 | 508.0 | Transmembrane | Helical |
Hgene | ALG6 | chr1:63836730 | chr1:116569514 | ENST00000371108 | - | 2 | 15 | 473_493 | 27 | 508.0 | Transmembrane | Helical |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369502 | 3 | 6 | 111_131 | 199 | 246.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369502 | 3 | 6 | 141_161 | 199 | 246.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369502 | 3 | 6 | 165_187 | 199 | 246.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369502 | 3 | 6 | 22_42 | 199 | 246.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369503 | 3 | 12 | 111_131 | 199 | 548.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369503 | 3 | 12 | 141_161 | 199 | 548.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369503 | 3 | 12 | 165_187 | 199 | 548.0 | Transmembrane | Helical | |
Tgene | SLC22A15 | chr1:63836730 | chr1:116569514 | ENST00000369503 | 3 | 12 | 22_42 | 199 | 548.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for ALG6-SLC22A15 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>4032_4032_1_ALG6-SLC22A15_ALG6_chr1_63836730_ENST00000263440_SLC22A15_chr1_116569514_ENST00000369502_length(transcript)=908nt_BP=290nt GGATACTTCTACATAGACATAATCAAGTTTTGACTATTTGGAAACCAAGCATCATTAAAATTCTCTCAAACTCCTAATTGCGAAGAATCG ATAACATTTCAAGAAGTGATAACATTTCTCTGAACAAGAAAAGAAGTGATTGACCACGTTTTAAAAGTACTCTGGCACTGGTGCTGTGTT TTCTTCCCCTCCCTAAATTTGAAGAACTATGGAGAAATGGTACTTGATGACAGTAGTGGTTTTAATAGGACTAACAGTACGATGGACAGT GTCTCTTAATTCTTATTCAGGATCGATTGGCGGCCTGTTCTTTGCAGTTGGCATTGCCCAATATGCCCTGTTAGGATACTTCATCCGCTC CTGGAGGACCCTAGCCATTCTGGTTAACCTGCAGGGAACGGTGGTCTTTCTCTTATCTTTGGTCGACTGAGTGAGGCTGAAGAGGCGCTG TACCTCATTGCCAAGAGGAACCGCAAACTCAAGTGCACGTTCTCACTAACACACCCAGCCAACAGGAGCTGCAGGGAGACTGGAAGTTTC CTGGATCTCTTTCGTTACCGGGTCCTGTTAGGACACACTTTGATCCTGATGTTCATCTGGTAATTATACTAAGGCGTGTTCTGTTGCTCT TTAACTAAGGTTGCTCGAGCTTCTCTTGATATCCTGCTCCTTCTTCAGGGTACAGGGAATTTTACCTCTTTTGTTAGCTTGAGGTTGTTT TCTCAACAGCAAGTCTCCTGATCCTTAGCGCCTGGTTTTCTGCTTGCGCAGCCCCGTCTTTCTCAAGTAGCAGATGATAGTGCCTGATGG GCAGGTCCACTGAGCTTGAGTAAGTAGACATCAGAAGCACATCTTTGCTTTTGAGGTATTTATCATAAATATTTAAGCCTTCCTGCCCCT >4032_4032_1_ALG6-SLC22A15_ALG6_chr1_63836730_ENST00000263440_SLC22A15_chr1_116569514_ENST00000369502_length(amino acids)=73AA_BP=21 -------------------------------------------------------------- >4032_4032_2_ALG6-SLC22A15_ALG6_chr1_63836730_ENST00000263440_SLC22A15_chr1_116569514_ENST00000369503_length(transcript)=4282nt_BP=290nt GGATACTTCTACATAGACATAATCAAGTTTTGACTATTTGGAAACCAAGCATCATTAAAATTCTCTCAAACTCCTAATTGCGAAGAATCG ATAACATTTCAAGAAGTGATAACATTTCTCTGAACAAGAAAAGAAGTGATTGACCACGTTTTAAAAGTACTCTGGCACTGGTGCTGTGTT TTCTTCCCCTCCCTAAATTTGAAGAACTATGGAGAAATGGTACTTGATGACAGTAGTGGTTTTAATAGGACTAACAGTACGATGGACAGT GTCTCTTAATTCTTATTCAGGATCGATTGGCGGCCTGTTCTTTGCAGTTGGCATTGCCCAATATGCCCTGTTAGGATACTTCATCCGCTC CTGGAGGACCCTAGCCATTCTGGTTAACCTGCAGGGAACGGTGGTCTTTCTCTTATCTTTATTCATTCCTGAATCACCTCGTTGGTTATA CTCCCAGGGTCGACTGAGTGAGGCTGAAGAGGCGCTGTACCTCATTGCCAAGAGGAACCGCAAACTCAAGTGCACGTTCTCACTAACACA CCCAGCCAACAGGAGCTGCAGGGAGACTGGAAGTTTCCTGGATCTCTTTCGTTACCGGGTCCTGTTAGGACACACTTTGATCCTGATGTT CATCTGGTTTGTGTGCAGCTTGGTGTATTATGGCCTAACTCTGAGTGCGGGTGATCTAGGTGGAAGTATTTATGCCAACCTGGCCCTGTC TGGCCTCATAGAGATTCCATCTTACCCTCTCTGTATCTACTTGATTAACCAAAAATGGTTTGGTCGGAAGCGAACATTATCAGCATTTCT GTGCCTAGGAGGACTGGCTTGTCTTATTGTAATGTTTCTTCCAGAAAAGAAAGACACAGGTGTGTTTGCAGTGGTGAACAGCCATTCCTT GTCCTTGCTGGGGAAGCTGACCATCAGTGCTGCCTTTAACATTGTTTATATCTACACCTCTGAGCTTTACCCTACAGTCATCAGGAATGT TGGGCTTGGAACTTGTTCCATGTTCTCCCGAGTTGGTGGGATTATTGCTCCCTTCATCCCCTCACTGAAATATGTGCAATGGTCTTTACC ATTCATTGTCTTCGGAGCCACGGGTCTGACCTCCGGCCTCCTGAGTTTGTTATTGCCGGAGACCCTTAACAGTCCGCTGCTAGAAACATT CTCCGACCTTCAGGTGTATTCGTATCGCAGGCTGGGAGAAGAAGCATTATCTTTACAGGCTTTGGACCCCCAACAGTGTGTGGACAAGGA GAGCTCTTTAGGGAGTGAGAGTGAGGAAGAGGAAGAATTTTATGATGCAGATGAAGAGACTCAGATGATCAAGTGAAGAGCCCCAGATTC CCCCTAAGAAGCAAAGGATCGTCTTTTATGCCTCTGGCTAAGGCAGGTTCTTCCATGACTCCTAAGAGAGTTGTAAAAATAGAGGCTTGG CTTGAATGTACATAGATGGTACCTGGCATGGACTGATGTTTTTAGGCACAGAAGTTGGAGAAGAGATTTCATGAAAGACAACATCACTGC ATTGAGAGAATAGTTGTTAATTTGTTTAGAATTTAAGTTCTACTCAGAATCATAACATCTGGCAGAACAGCCCAAACCCACATTCCAAAG TGGTAGGCTCATTTGTTTCTAGAGATTTCATCATGTCGCTTTTCCTTCATCATGATCTAAATAAAGGCAGATATGTAAAATTTCTCACCA TTTTGGTGGGGTAAGATAAGCTATTATTAAGATTTAATCCTTATACCATGTTGGACATTTGCCCCTATCAGTTGCTCCTCAGGAATCTTC TGGTACAGGTTAACATCAGCATTTTCATTTTGTGTCCAGGGAAAAGCACCCAGAGGTCATCTGTGTGTCCCGAGACCCTCCAGCTTTTTC TTAGCTGATGAAATATGAGTCCTCAGCTTGGTTCCCAGCCTGCTGATTGACTTGGGCTGCTGGTGCCTTGAGTCCCACAGATGATTCATT AGGAAAAGCCAGATATACCAAAGCGGTTTACTCAGAGTCAGGGGTGTAGCTCTGGCTGCCTGTCAGCTCCCTTGGATACTATATTGTATG ATTTCTTCCTTTCCCACTAATATGCACATCCAGAAAAATTTCCATCTGAGATTCTAGTACTTCAAAATCATGCATAGTAAATGAGAAAGC TTTAAGTAGAGGGCAGTTAAACAGTGACATGTTGAGCACCTGGAGGAAAAAAAAGGTGCAGTTTTTAATAAGAGAGAAAATGAAATTATC TTTGATAAATTTTTGTTTGTTTTGCTTTCAGCATTGTGCCATGAGGGATTTGGACAATATTTAAGAACTTCTTGTCCTAGATCAGCCCCA ATCTGTTTAATCAAAATGGAAGGTTCAGTAATTTCATGGGAAACCTTGGTTTTTCATTAAGTGCTACCAACTTTCAAGTGAATCTTGTAT TTGATTTCCTAAAATCATGTCTTGAAAACATGTTTTCTCATGAAACTTGAATACTATCTCAAATAGGAATATAAACCTGGAGTCAACAAG CTTAGGCAGCATTGATTTAGGTCACTTTCCCAGTGAGGAAAATTTCTGTGTTTTCAGAATTTCCATTTCTACTAACCTCTTGGAGAAAAA GAAATTGAATTAGAGGTAAATAGAAGACGTCACTGTGGCTGCTTCTGGAAGTGCTGGAAGCATCACCCCAATTGGCTCCAAATACTGTCA TGTTTTCTTGCACACTGACTTCTGGTTTCCACTGTATCAGTATGTACCTTTGTAATTGTTATTTTTATGTCTTTTATGCCCTTGATTATT AGTTGGGCTCTTCATAAACAGAGGCCATCTCTACTACTGTTTATTTTTCCCTGCTGTGCCCAGAACATTGGCGTAGACACAGTAAGAACC TAGTAAATATTACTGTTTCTAGCCATCAGGGAGATTGTGGAACTCCTCCCAGTATAATTTTTACAAACTCCAAGCAAATCTGACCCAAAC TCCCAAATTGTCAAGTCCTGCTTAACTTTCTCTGGAAAATAGACCCCTTCTCAACATCAGAATAGGAAGAGAGGAAGAACTTACAAAGAC ACTTAAAAGTTATTCTTAAATGGTGGTTGGGCATTTAAAACAGTGAACTAACATATATATAATTTTTGATTAGTTGGAGCTTTCTTTGTA TTATAAGAGTAATATATCTCATTACAGAAAATTTGGAAACTATAAATTTAGAAACGTATCACCCATACGTCCAACATCGAAAGAAAACCA GTGTTATGACTTTGTTCCATTTGAAGACTAATTGGGAGTCCATCTCTCTATTGGCACTGGGTTCGATTGCCTCTGGCTAATAGAGTTCAA TTAGTTCTATCCCTGGGTTTCCTTTCTTAGCTATGGGGTGGAAGATAGGAGGGGGAGATCTACAATTTGAATATGTGTTACTTAATAAGG CTAGGCTGGCCATCAGTTGCTTATTTCAGATGTGTCACTAAATTTTCCTTCTAGATGGTCCTTGAGCAAAACTTAATAATTACTGTTTTT TATTTCCACTGCCTTTATAAAATCAAAATTTTCTCCTTTTGATAAAAACTGTTGAATACTATTGATGTAGAGAATGTGTATATGTGTATA TTTGCATTGATTAAATTATTGGAAAACTTTTCATTGACAGGTAATGTATTTTGGTTGTGCGGATGGTTTGTAAAAAGTATCCTGTTTTTT TAATTCTATTCAAAATTAAAAATTTTTTTTCCTAAAATAAAGCAAGAAAAATAAATGTAAGATATATAAGAAACCCCAGAGTTTCCAGGG TGAAAGTTCACATTAGCAGCTTGTCCAAAATATTTACACCTCACAAATATTTTGAAAGAAACCATGTTGAAATTTTCTGATTTTGTGAGT TACAACCACAGCCCAGTAAAACCAATACTTGTTATTTGGCTACTTTCAAGCAATGCAGATATTCTTTAGTATTTAAAAATGAGCAAATAA ACAAAATGAGGCAAATAAATGAAGAAAATGAGTTTCTGAGACACTGTTTAGGTAACCATAAATCAGACAGATATTTTTATGGTGGGCAAA TTGATGAAGATACTTTTAGTAGGTGATTTATATTCATAACAAATACATATTGAAATAATTGTCACTACTGTATCAGAATTAAAAACCAGC TTCACATTAGGACTTCTCCATACAAATGCTTTATCATTGGTTCTTAAATTGGAAAAATATCTATAAATGATTACATTTTTAAGCTAAATA >4032_4032_2_ALG6-SLC22A15_ALG6_chr1_63836730_ENST00000263440_SLC22A15_chr1_116569514_ENST00000369503_length(amino acids)=375AA_BP=21 MEKWYLMTVVVLIGLTVRWTVSLNSYSGSIGGLFFAVGIAQYALLGYFIRSWRTLAILVNLQGTVVFLLSLFIPESPRWLYSQGRLSEAE EALYLIAKRNRKLKCTFSLTHPANRSCRETGSFLDLFRYRVLLGHTLILMFIWFVCSLVYYGLTLSAGDLGGSIYANLALSGLIEIPSYP LCIYLINQKWFGRKRTLSAFLCLGGLACLIVMFLPEKKDTGVFAVVNSHSLSLLGKLTISAAFNIVYIYTSELYPTVIRNVGLGTCSMFS RVGGIIAPFIPSLKYVQWSLPFIVFGATGLTSGLLSLLLPETLNSPLLETFSDLQVYSYRRLGEEALSLQALDPQQCVDKESSLGSESEE -------------------------------------------------------------- >4032_4032_3_ALG6-SLC22A15_ALG6_chr1_63836730_ENST00000371108_SLC22A15_chr1_116569514_ENST00000369502_length(transcript)=1005nt_BP=387nt CGGAAGGCCGGAGGGGCAGTCCGCCGCGGGGGCGAGCGCGCATGCGCCTTCCTGGGACCCACGGCAGGCGCGAATCCCAGCGGCCGGCGG GCGGCGGGGATACTTCTACATAGACATAATCAAGTTTTGACTATTTGGAAACCAAGCATCATTAAAATTCTCTCAAACTCCTAATTGCGA AGAATCGATAACATTTCAAGAAGTGATAACATTTCTCTGAACAAGAAAAGAAGTGATTGACCACGTTTTAAAAGTACTCTGGCACTGGTG CTGTGTTTTCTTCCCCTCCCTAAATTTGAAGAACTATGGAGAAATGGTACTTGATGACAGTAGTGGTTTTAATAGGACTAACAGTACGAT GGACAGTGTCTCTTAATTCTTATTCAGGATCGATTGGCGGCCTGTTCTTTGCAGTTGGCATTGCCCAATATGCCCTGTTAGGATACTTCA TCCGCTCCTGGAGGACCCTAGCCATTCTGGTTAACCTGCAGGGAACGGTGGTCTTTCTCTTATCTTTGGTCGACTGAGTGAGGCTGAAGA GGCGCTGTACCTCATTGCCAAGAGGAACCGCAAACTCAAGTGCACGTTCTCACTAACACACCCAGCCAACAGGAGCTGCAGGGAGACTGG AAGTTTCCTGGATCTCTTTCGTTACCGGGTCCTGTTAGGACACACTTTGATCCTGATGTTCATCTGGTAATTATACTAAGGCGTGTTCTG TTGCTCTTTAACTAAGGTTGCTCGAGCTTCTCTTGATATCCTGCTCCTTCTTCAGGGTACAGGGAATTTTACCTCTTTTGTTAGCTTGAG GTTGTTTTCTCAACAGCAAGTCTCCTGATCCTTAGCGCCTGGTTTTCTGCTTGCGCAGCCCCGTCTTTCTCAAGTAGCAGATGATAGTGC CTGATGGGCAGGTCCACTGAGCTTGAGTAAGTAGACATCAGAAGCACATCTTTGCTTTTGAGGTATTTATCATAAATATTTAAGCCTTCC >4032_4032_3_ALG6-SLC22A15_ALG6_chr1_63836730_ENST00000371108_SLC22A15_chr1_116569514_ENST00000369502_length(amino acids)=73AA_BP=21 -------------------------------------------------------------- >4032_4032_4_ALG6-SLC22A15_ALG6_chr1_63836730_ENST00000371108_SLC22A15_chr1_116569514_ENST00000369503_length(transcript)=4379nt_BP=387nt CGGAAGGCCGGAGGGGCAGTCCGCCGCGGGGGCGAGCGCGCATGCGCCTTCCTGGGACCCACGGCAGGCGCGAATCCCAGCGGCCGGCGG GCGGCGGGGATACTTCTACATAGACATAATCAAGTTTTGACTATTTGGAAACCAAGCATCATTAAAATTCTCTCAAACTCCTAATTGCGA AGAATCGATAACATTTCAAGAAGTGATAACATTTCTCTGAACAAGAAAAGAAGTGATTGACCACGTTTTAAAAGTACTCTGGCACTGGTG CTGTGTTTTCTTCCCCTCCCTAAATTTGAAGAACTATGGAGAAATGGTACTTGATGACAGTAGTGGTTTTAATAGGACTAACAGTACGAT GGACAGTGTCTCTTAATTCTTATTCAGGATCGATTGGCGGCCTGTTCTTTGCAGTTGGCATTGCCCAATATGCCCTGTTAGGATACTTCA TCCGCTCCTGGAGGACCCTAGCCATTCTGGTTAACCTGCAGGGAACGGTGGTCTTTCTCTTATCTTTATTCATTCCTGAATCACCTCGTT GGTTATACTCCCAGGGTCGACTGAGTGAGGCTGAAGAGGCGCTGTACCTCATTGCCAAGAGGAACCGCAAACTCAAGTGCACGTTCTCAC TAACACACCCAGCCAACAGGAGCTGCAGGGAGACTGGAAGTTTCCTGGATCTCTTTCGTTACCGGGTCCTGTTAGGACACACTTTGATCC TGATGTTCATCTGGTTTGTGTGCAGCTTGGTGTATTATGGCCTAACTCTGAGTGCGGGTGATCTAGGTGGAAGTATTTATGCCAACCTGG CCCTGTCTGGCCTCATAGAGATTCCATCTTACCCTCTCTGTATCTACTTGATTAACCAAAAATGGTTTGGTCGGAAGCGAACATTATCAG CATTTCTGTGCCTAGGAGGACTGGCTTGTCTTATTGTAATGTTTCTTCCAGAAAAGAAAGACACAGGTGTGTTTGCAGTGGTGAACAGCC ATTCCTTGTCCTTGCTGGGGAAGCTGACCATCAGTGCTGCCTTTAACATTGTTTATATCTACACCTCTGAGCTTTACCCTACAGTCATCA GGAATGTTGGGCTTGGAACTTGTTCCATGTTCTCCCGAGTTGGTGGGATTATTGCTCCCTTCATCCCCTCACTGAAATATGTGCAATGGT CTTTACCATTCATTGTCTTCGGAGCCACGGGTCTGACCTCCGGCCTCCTGAGTTTGTTATTGCCGGAGACCCTTAACAGTCCGCTGCTAG AAACATTCTCCGACCTTCAGGTGTATTCGTATCGCAGGCTGGGAGAAGAAGCATTATCTTTACAGGCTTTGGACCCCCAACAGTGTGTGG ACAAGGAGAGCTCTTTAGGGAGTGAGAGTGAGGAAGAGGAAGAATTTTATGATGCAGATGAAGAGACTCAGATGATCAAGTGAAGAGCCC CAGATTCCCCCTAAGAAGCAAAGGATCGTCTTTTATGCCTCTGGCTAAGGCAGGTTCTTCCATGACTCCTAAGAGAGTTGTAAAAATAGA GGCTTGGCTTGAATGTACATAGATGGTACCTGGCATGGACTGATGTTTTTAGGCACAGAAGTTGGAGAAGAGATTTCATGAAAGACAACA TCACTGCATTGAGAGAATAGTTGTTAATTTGTTTAGAATTTAAGTTCTACTCAGAATCATAACATCTGGCAGAACAGCCCAAACCCACAT TCCAAAGTGGTAGGCTCATTTGTTTCTAGAGATTTCATCATGTCGCTTTTCCTTCATCATGATCTAAATAAAGGCAGATATGTAAAATTT CTCACCATTTTGGTGGGGTAAGATAAGCTATTATTAAGATTTAATCCTTATACCATGTTGGACATTTGCCCCTATCAGTTGCTCCTCAGG AATCTTCTGGTACAGGTTAACATCAGCATTTTCATTTTGTGTCCAGGGAAAAGCACCCAGAGGTCATCTGTGTGTCCCGAGACCCTCCAG CTTTTTCTTAGCTGATGAAATATGAGTCCTCAGCTTGGTTCCCAGCCTGCTGATTGACTTGGGCTGCTGGTGCCTTGAGTCCCACAGATG ATTCATTAGGAAAAGCCAGATATACCAAAGCGGTTTACTCAGAGTCAGGGGTGTAGCTCTGGCTGCCTGTCAGCTCCCTTGGATACTATA TTGTATGATTTCTTCCTTTCCCACTAATATGCACATCCAGAAAAATTTCCATCTGAGATTCTAGTACTTCAAAATCATGCATAGTAAATG AGAAAGCTTTAAGTAGAGGGCAGTTAAACAGTGACATGTTGAGCACCTGGAGGAAAAAAAAGGTGCAGTTTTTAATAAGAGAGAAAATGA AATTATCTTTGATAAATTTTTGTTTGTTTTGCTTTCAGCATTGTGCCATGAGGGATTTGGACAATATTTAAGAACTTCTTGTCCTAGATC AGCCCCAATCTGTTTAATCAAAATGGAAGGTTCAGTAATTTCATGGGAAACCTTGGTTTTTCATTAAGTGCTACCAACTTTCAAGTGAAT CTTGTATTTGATTTCCTAAAATCATGTCTTGAAAACATGTTTTCTCATGAAACTTGAATACTATCTCAAATAGGAATATAAACCTGGAGT CAACAAGCTTAGGCAGCATTGATTTAGGTCACTTTCCCAGTGAGGAAAATTTCTGTGTTTTCAGAATTTCCATTTCTACTAACCTCTTGG AGAAAAAGAAATTGAATTAGAGGTAAATAGAAGACGTCACTGTGGCTGCTTCTGGAAGTGCTGGAAGCATCACCCCAATTGGCTCCAAAT ACTGTCATGTTTTCTTGCACACTGACTTCTGGTTTCCACTGTATCAGTATGTACCTTTGTAATTGTTATTTTTATGTCTTTTATGCCCTT GATTATTAGTTGGGCTCTTCATAAACAGAGGCCATCTCTACTACTGTTTATTTTTCCCTGCTGTGCCCAGAACATTGGCGTAGACACAGT AAGAACCTAGTAAATATTACTGTTTCTAGCCATCAGGGAGATTGTGGAACTCCTCCCAGTATAATTTTTACAAACTCCAAGCAAATCTGA CCCAAACTCCCAAATTGTCAAGTCCTGCTTAACTTTCTCTGGAAAATAGACCCCTTCTCAACATCAGAATAGGAAGAGAGGAAGAACTTA CAAAGACACTTAAAAGTTATTCTTAAATGGTGGTTGGGCATTTAAAACAGTGAACTAACATATATATAATTTTTGATTAGTTGGAGCTTT CTTTGTATTATAAGAGTAATATATCTCATTACAGAAAATTTGGAAACTATAAATTTAGAAACGTATCACCCATACGTCCAACATCGAAAG AAAACCAGTGTTATGACTTTGTTCCATTTGAAGACTAATTGGGAGTCCATCTCTCTATTGGCACTGGGTTCGATTGCCTCTGGCTAATAG AGTTCAATTAGTTCTATCCCTGGGTTTCCTTTCTTAGCTATGGGGTGGAAGATAGGAGGGGGAGATCTACAATTTGAATATGTGTTACTT AATAAGGCTAGGCTGGCCATCAGTTGCTTATTTCAGATGTGTCACTAAATTTTCCTTCTAGATGGTCCTTGAGCAAAACTTAATAATTAC TGTTTTTTATTTCCACTGCCTTTATAAAATCAAAATTTTCTCCTTTTGATAAAAACTGTTGAATACTATTGATGTAGAGAATGTGTATAT GTGTATATTTGCATTGATTAAATTATTGGAAAACTTTTCATTGACAGGTAATGTATTTTGGTTGTGCGGATGGTTTGTAAAAAGTATCCT GTTTTTTTAATTCTATTCAAAATTAAAAATTTTTTTTCCTAAAATAAAGCAAGAAAAATAAATGTAAGATATATAAGAAACCCCAGAGTT TCCAGGGTGAAAGTTCACATTAGCAGCTTGTCCAAAATATTTACACCTCACAAATATTTTGAAAGAAACCATGTTGAAATTTTCTGATTT TGTGAGTTACAACCACAGCCCAGTAAAACCAATACTTGTTATTTGGCTACTTTCAAGCAATGCAGATATTCTTTAGTATTTAAAAATGAG CAAATAAACAAAATGAGGCAAATAAATGAAGAAAATGAGTTTCTGAGACACTGTTTAGGTAACCATAAATCAGACAGATATTTTTATGGT GGGCAAATTGATGAAGATACTTTTAGTAGGTGATTTATATTCATAACAAATACATATTGAAATAATTGTCACTACTGTATCAGAATTAAA AACCAGCTTCACATTAGGACTTCTCCATACAAATGCTTTATCATTGGTTCTTAAATTGGAAAAATATCTATAAATGATTACATTTTTAAG >4032_4032_4_ALG6-SLC22A15_ALG6_chr1_63836730_ENST00000371108_SLC22A15_chr1_116569514_ENST00000369503_length(amino acids)=375AA_BP=21 MEKWYLMTVVVLIGLTVRWTVSLNSYSGSIGGLFFAVGIAQYALLGYFIRSWRTLAILVNLQGTVVFLLSLFIPESPRWLYSQGRLSEAE EALYLIAKRNRKLKCTFSLTHPANRSCRETGSFLDLFRYRVLLGHTLILMFIWFVCSLVYYGLTLSAGDLGGSIYANLALSGLIEIPSYP LCIYLINQKWFGRKRTLSAFLCLGGLACLIVMFLPEKKDTGVFAVVNSHSLSLLGKLTISAAFNIVYIYTSELYPTVIRNVGLGTCSMFS RVGGIIAPFIPSLKYVQWSLPFIVFGATGLTSGLLSLLLPETLNSPLLETFSDLQVYSYRRLGEEALSLQALDPQQCVDKESSLGSESEE -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ALG6-SLC22A15 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ALG6-SLC22A15 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ALG6-SLC22A15 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ALG6 | C2930997 | Congenital disorder of glycosylation type 1C | 8 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | C0009402 | Colorectal Carcinoma | 1 | CTD_human | |
Tgene | C0009404 | Colorectal Neoplasms | 1 | CTD_human |